Drug Trial Radar · NCT01777152
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
Last checked: Nov 19, 2026Latest source record: Nov 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
452
Actual
Start
Jan 31, 2013
Primary completion
Aug 15, 2018
Study completion Oct 2, 2020
Sponsor
- Lead sponsor
- Seagen Inc.Pfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- Millennium Pharmaceuticals, Inc.
- First posted
- Jan 28, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, randomized, multicenter, phase 3 clinical trial to compare the efficacy and safety of brentuximab vedotin in combination with CHP with the standard-of-care CHOP in patients with CD30-positive mature T-cell lymphomas.
Conditions
- Anaplastic Large-Cell Lymphoma
- Non-Hodgkin Lymphoma
- T-Cell Lymphoma
Interventions
brentuximab vedotinDrug
1.8 mg/kg every 3 weeks by IV infusion for 6-8 cycles
doxorubicinDrug
50 mg/m2 every 3 weeks by IV infusion for 6-8 cycles
prednisoneDrug
100 mg on Days 1 to 5 of each 3-week cycle, orally for 6-8 cycles
vincristineDrug
1.4 mg/m2 (maximum 2 mg) every 3 weeks by IV infusion for 6-8 cycles
cyclophosphamideDrug
750 mg/m2 every 3 weeks by IV infusion for 6-8 cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival Per Independent Review Facility (IRF)Time frame: Up to 60 months
Locations
144 sites in 16 countries. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Gilbert, Arizona
City of Hope National Medical Center
Duarte, California
Stanford Cancer Center
Stanford, California
Shands Cancer Center / University of Florida
Gainesville, Florida
Orlando Health, Inc.
Orlando, Florida
University of Illinois at Chicago
Chicago, Illinois
Cardinal Bernardin Cancer Center / Loyola University Medical Center
Maywood, Illinois
Holden Comprehensive Cancer Center / University of Iowa
Iowa City, Iowa
University of Kansas Cancer Center
Westwood, Kansas
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts
Washington University School of Medicine
St Louis, Missouri
Memorial Sloan Kettering Cancer Center - Basking Ridge
Basking Ridge, New Jersey
Hackensack University Medical Center
Hackensack, New Jersey
Memorial Sloan Kettering Cancer Center - Commack
Commack, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Columbia University Medical Center
New York, New York
Weill Cornell Medical College
New York, New York
James P. Wilmot Cancer Center / University of Rochester Medical Center
Rochester, New York
Albert Einstein Cancer Center
The Bronx, New York
Montefiore Medical Center
The Bronx, New York
Jewish Hospital, The
Cincinnati, Ohio
Cleveland Clinic, The
Cleveland, Ohio
Mercy Clinic Oncology
Oklahoma City, Oklahoma
Thomas Jefferson University
Philadelphia, Pennsylvania
Sarah Cannon Research Institute
Nashville, Tennessee
Charles A. Sammons Cancer Center / Baylor University Medical Center
Dallas, Texas
MD Anderson Cancer Center / University of Texas
Houston, Texas
University of Virginia
Charlottesville, Virginia
Virginia Commonwealth University Medical Center
Richmond, Virginia
Benaroya Research Institute/Virginia Mason Medical Center
Seattle, Washington
Seattle Cancer Care Alliance / University of Washington
Seattle, Washington
Royal Adelaide Hospital
Adelaide, Australia
Moorabbin Hospital
Bentleigh East, Australia
Icon Cancer Care Chermside
Chermside, Australia
Icon Cancer Care South Brisbane
Chermside, Australia
Icon Cancer Care Southport
Chermside, Australia
Icon Cancer Care Wesley
Chermside, Australia
Monash Medical Centre
Clayton, Australia
Concord Repatriation General Hospital
Concord, Australia
Showing 40 of 144 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.